Physician profile
Charles K Lee
NPI 1487635298
$199,701.80
in general payments reported to CMS, 2019-2025
47 companies · $39K in 2025
The $39K reported for 2025 was more than what 99% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77K · 2020: $27K · 2021: $22K · 2022: $14K · 2023: $14K · 2024: $8,031 · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $48K · Food and Beverage: $9,224 · Travel and Lodging: $3,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $47,540.62 |
| Food and Beverage | $9,223.79 |
| Travel and Lodging | $3,750.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $59,428.19 | 2019-2025 | |
| Medela Ag | $57,292.89 | 2019-2022 | |
| Acelrx Pharmaceuticals, INC. | $28,580.53 | 2019-2023 | Dsuvia |
| Baxter Healthcare | $18,507.87 | 2019-2022 | |
| Integra Lifesciences Corporation | $14,226.88 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Medaxis LLC | $4,500.00 | 2019 | |
| Medline Industries Lp | $4,283.77 | 2019-2023 | |
| Urgo Medical North America, LLC | $3,803.40 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag, Urgok2 |
| Medela LLC | $2,198.50 | 2019-2024 | Invia Motion Endure |
| Tela Bio, INC. | $1,000.00 | 2024 | Ovitex 2s |
| Endo Pharmaceuticals INC. | $483.62 | 2019-2021 | |
| Merz North America, INC. | $481.48 | 2020-2025 | Xeomin |
| Avita Medical Americas, LLC | $427.65 | 2024 | |
| Stryker Corporation | $371.67 | 2021 | |
| Abbvie INC. | $357.57 | 2023-2025 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Access Pro Medical, LLC | $353.76 | 2025 | Matriderm |
| Aroa Biosurgery Incorporated | $341.74 | 2024 | |
| Allergan, INC. | $315.53 | 2019-2022 | |
| Tei Biosciences INC | $309.82 | 2019 | |
| Zimmer Biomet Holdings, INC. | $286.94 | 2019 | |
| Scanlan International INC | $257.91 | 2019 | |
| Kerecis Limited | $242.54 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Polynovo North America LLC | $235.71 | 2022-2024 | Novosorb Btm |
| Derma Sciences, INC. | $199.23 | 2019 | |
| Sanara Medtech INC. | $172.14 | 2021 | |
| Polarityte, INC. | $137.52 | 2019-2020 | |
| Mentor Worldwide LLC | $116.44 | 2019-2020 | |
| Smith+Nephew, INC. | $90.32 | 2020 | |
| Axogen | $87.43 | 2019 | |
| Galderma Laboratories, L.P. | $54.82 | 2022-2023 | Dysport |
| Coloplast Corp | $54.38 | 2023 | Titan |
| Astellas Pharma US INC | $53.53 | 2024 | Veozah |
| Sientra, INC. | $49.38 | 2020 | |
| Dynasplint Systems INC. | $42.07 | 2020 | |
| Vertical Pharmaceuticals, LLC | $39.11 | 2023 | Dsuvia |
| Acell, INC. | $37.95 | 2019 | |
| Ethicon US, LLC | $35.19 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $33.90 | 2025 | Exparel |
| Mesh Suture INC | $31.88 | 2025 | |
| Acera Surgical, INC. | $29.51 | 2024 | Restrata Wound Matrix |
| Solta Medical, A Division of Bausch Health US, LLC | $24.84 | 2024 | |
| Innovation Technologies INC | $24.78 | 2020 | |
| Vioptix INC | $24.05 | 2024 | T. Ox Tissue Oximeter |
| Convatec INC. | $23.47 | 2019 | |
| Davol INC. | $20.59 | 2019 | |
| Tactile Systems Technology INC | $18.84 | 2019 | |
| Trevena, INC. | $12.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.